VIVEVE MEDICAL INC (VIVE) Stock Analyst Ratings
USA - NASDAQ:VIVE - US92852W5013 - Common Stock
0.2201 USD
-0.04 (-15.35%)
0.2151 USD
0 (-2.27%)
ChartMill assigns a Buy % Consensus number of 85% to VIVE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.77. This target is 2066.52% above the current price.
VIVE was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about VIVE.
In the previous month the buy percentage consensus was at a similar level.
VIVE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
VIVEVE MEDICAL INC / VIVE FAQ
What is the average price target for VIVEVE MEDICAL INC (VIVE) stock?
8 analysts have analysed VIVE and the average price target is 4.77 USD. This implies a price increase of 2066.52% is expected in the next year compared to the current price of 0.2201.
What is the consensus rating for VIVE stock?
The consensus rating for VIVEVE MEDICAL INC (VIVE) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover VIVEVE MEDICAL INC (VIVE) stock?
The number of analysts covering VIVEVE MEDICAL INC (VIVE) is 8.